Matches in Nanopublications for { ?s ?p "[Is there a role for JAK inhibitors in BCR-ABL1-negative myeloproliferative neoplasms other than myelofibrosis?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[Is there a role for JAK inhibitors in BCR-ABL1-negative myeloproliferative neoplasms other than myelofibrosis?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Is there a role for JAK inhibitors in BCR-ABL1-negative myeloproliferative neoplasms other than myelofibrosis?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Is there a role for JAK inhibitors in BCR-ABL1-negative myeloproliferative neoplasms other than myelofibrosis?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Is there a role for JAK inhibitors in BCR-ABL1-negative myeloproliferative neoplasms other than myelofibrosis?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Is there a role for JAK inhibitors in BCR-ABL1-negative myeloproliferative neoplasms other than myelofibrosis?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Is there a role for JAK inhibitors in BCR-ABL1-negative myeloproliferative neoplasms other than myelofibrosis?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1249055.RACoobGj4XbSasWwrki4QMRPmJfaaXL5yj4ZxTn3ecL5I130_assertion description "[Is there a role for JAK inhibitors in BCR-ABL1-negative myeloproliferative neoplasms other than myelofibrosis?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249055.RACoobGj4XbSasWwrki4QMRPmJfaaXL5yj4ZxTn3ecL5I130_provenance.
- NP1249052.RAqPYh7gYJt1gz-VdoiI1qpIr54rcfwCV8qc_92nRb050130_assertion description "[Is there a role for JAK inhibitors in BCR-ABL1-negative myeloproliferative neoplasms other than myelofibrosis?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249052.RAqPYh7gYJt1gz-VdoiI1qpIr54rcfwCV8qc_92nRb050130_provenance.
- NP1249049.RAEY4nn1_aS3GVf5feTnPWFrcL9xlIqnVrWitE3Vwnl9o130_assertion description "[Is there a role for JAK inhibitors in BCR-ABL1-negative myeloproliferative neoplasms other than myelofibrosis?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249049.RAEY4nn1_aS3GVf5feTnPWFrcL9xlIqnVrWitE3Vwnl9o130_provenance.
- NP1249047.RA8pbNIijnIwL1U0oKLm64zoqSII-DmNsuX-tXIFUINww130_assertion description "[Is there a role for JAK inhibitors in BCR-ABL1-negative myeloproliferative neoplasms other than myelofibrosis?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249047.RA8pbNIijnIwL1U0oKLm64zoqSII-DmNsuX-tXIFUINww130_provenance.